Madrigal Pharmaceuticals (MDGL) total liabilities

Total liabilities · fiscal 2025
$656.90M

Madrigal Pharmaceuticals (MDGL) had total liabilities of $656.90M at the end of fiscal 2025 (December 31, 2025). That is 128.2% higher than the $287.86M of fiscal 2024. Figures as of 18 Nov 2026, 19:23 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$656.90M
Change on fiscal 2024
+128.2%
Growth, 5 years
+69.4% a year
Highest on record
$656.90Mfiscal 2025
Lowest on record
$4.80Mfiscal 2016
Fiscal years on record
112012–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Madrigal Pharmaceuticals total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 69.4% a year. Across the 11 fiscal years on record (2012–2025), the highest was $656.90M in fiscal 2025 and the lowest $4.80M in fiscal 2016.

History · 11 fiscal years

Total liabilities by fiscal year

Madrigal Pharmaceuticals total liabilities, year by year

Madrigal Pharmaceuticals (MDGL) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$656.90M 128.2% up
2024$287.86M 22.4% up
2023$235.21M 42.4% up
2022$165.18M 113.9% up
2021$77.23M 64.2% up
2020$47.03M 84.5% up
2019$25.49M 201.9% up
2018$8.44M 16.0% down
2017$10.05M 109.5% up
2016$4.80M—
2012$27.95M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

More on MDGL

Madrigal Pharmaceuticals, figure by figure

Madrigal Pharmaceuticals (MDGL) overview: price, valuation and scorecardAll health care companies by market value

Madrigal Pharmaceuticals total liabilities: questions and answers

How large are Madrigal Pharmaceuticals's total liabilities?

Madrigal Pharmaceuticals (MDGL) had total liabilities of $656.90M at the end of fiscal 2025 (December 31, 2025). That is 128.2% higher than the $287.86M of fiscal 2024.

What is the growth rate of Madrigal Pharmaceuticals's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 69.4% a year.

What are the highest and lowest total liabilities figures on record for Madrigal Pharmaceuticals?

Across the 11 fiscal years on record (2012–2025), the highest was $656.90M in fiscal 2025 and the lowest $4.80M in fiscal 2016.

How is Madrigal Pharmaceuticals's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Madrigal Pharmaceuticals it is on record here for 11 fiscal years, 2012 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Madrigal Pharmaceuticals (MDGL) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/MDGL/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.